Drug-induced lupus: an update on its dermatologic aspects.
about
Drug Induced Lupus Erythematosus Due to Capecitabine and Bevacizumab Treatment Presenting with Prolonged Thrombocytopenia.A single-stranded DNA-cross-reactive immunogenic epitope of human homocysteine-inducible endoplasmic reticulum protein.Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden.Pharmacological regulators of autophagy and their link with modulators of lupus diseaseProton pump inhibitor-induced subacute cutaneous lupus erythematosusMethimazole-induced bullous systemic lupus erythematosus: a case report.Drug-induced lupus erythematosus with emphasis on skin manifestations and the role of anti-TNFα agentsTerbinafine-induced subacute cutaneous lupus erythematosus in two patients with systemic lupus erythematosus successfully treated with topical corticosteroids.Chilblain lupus erythematosus.Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates.The management of hypertensive emergencies in children after stem cell transplantation.TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists.Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with lupus erythematosus: a descriptive study of 17 cases from a national registry and review of the literature.Sequential use of biologics in moderate-to-severe plaque psoriasis: case studies illustrating an individualized approach.TNF blockade and cutaneous lupus erythematosus: where do we stand and where are we going?Systematic review of infliximab-induced autoantibodies and systemic lupus erythematosus.Immune-mediated inflammatory reactions and tumors as skin side effects of inflammatory bowel disease therapy.Drug-induced lupus: Including anti-tumour necrosis factor and interferon induced.Optimizing pharmacotherapy of systemic lupus erythematosus: the pharmacist role.Drug-induced photosensitivity: new insights into pathomechanisms and clinical variation through basic and applied science.Episcleritis Related to Drug-Induced Lupus Erythematosus following Infliximab Therapy: A Case Report.[Drug-induced subacute cutaneous lupus erythematosus: repeated occurrence following treatment with terbinafine].Drug-induced subacute cutaneous lupus erythematosus associated with nab-paclitaxel therapy.Splenic manifestations of chronic autoimmune disorder: a report of five cases with histiocytic necrotizing change in four cases.Drug-Induced Lupus Erythematosus Associated with Antiretroviral Therapy in a Patient with Human Immunodeficiency Virus: A Case Report.Drug-induced subacute cutaneous lupus erythematosus: evidence for differences from its idiopathic counterpart.The Cutaneous Spectrum of Lupus Erythematosus.Pyoderma gangrenosum: study of 21 patients and proposal of a 'clinicotherapeutic' classification.Subacute cutaneous lupus erythematosus induced by masitinib.[Secukinumab-induced subacute-cutaneous lupus erythematosus].S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV).A diffuse desquamative rash in an elderly male.Cutaneous lupus erythematosus induced by adalimumab
P2860
Q33428730-93F8E1E2-B441-4500-B3CA-00196705AD67Q33887369-BF694456-9D2A-461F-A216-06E3E90C4E00Q34031291-09180471-5FAC-476B-BABB-0019EDDF4300Q34402759-D5DB6E5A-B463-41E8-A4EB-924975621813Q34516486-9322CEB7-0AD0-43B1-BEBC-8BE8E1962F3EQ36079081-EC81CD6E-589E-4DEC-90FA-0629B2F7520CQ36579988-6E7A7BC7-196F-46EC-9655-823E5E04C2A2Q37327217-806318A4-B4BD-4C07-9681-0ED4EA0B0D7AQ37357697-ED026DAE-0E58-4273-B3B5-E4C275093794Q37778645-C210568D-793F-48BF-8B00-DFED063478C7Q37851883-1D0B0EAD-912D-4A70-A4E6-CC4FEC962137Q37867162-2F597941-E613-4ECC-8D4D-2E0B89E2DCA2Q37947682-3300E773-3AA0-49F0-9AC6-60B2BD5DA184Q38053456-B3F71F7B-98F7-4177-885F-6392573D3E28Q38125529-6F6D8E94-79B3-4438-A869-751654C2B114Q38161813-082ACDF8-FCF7-4483-AE7E-26E2D7C15366Q38179468-87204B14-7991-4BE3-83DD-E49F9C31D193Q38190033-26141A13-EF31-4C89-8038-B1F68C27C222Q38225438-D3FCB451-B30F-4774-AB7B-ADEDFDD83FF8Q38924006-49B8B7E0-4DFF-45DB-98F5-E9918ADE16E5Q41871391-7EAAA1E3-BE35-42B9-A003-978C3B4DECFCQ41922650-49EEE2AD-D964-4A63-AB0C-94AF40A43033Q42069226-B4F79A97-903E-44A2-9C5F-9CB4A7C40B57Q42263172-BE1B5D3A-0145-4E07-95DC-FAFD1C6BEBAAQ45324720-AAF22AD4-7774-4950-BA74-E17F1A06292CQ48264210-5051E61E-A363-45F2-BDA2-337C5C23CEA8Q48332079-A37AC4DE-7AA6-4A8C-83BB-86F26951055EQ48339240-6CE16FEF-82E0-4F2C-9C9F-96D5AFC802A1Q49904315-1980AC41-F0E6-443C-835F-9CE029D49F56Q50093692-FE314E1D-B47B-4A8D-86B3-22984CF783FBQ52836583-4D2E7A89-B51A-4838-B84E-B83C5C7AC00AQ54141055-3070016E-717D-4F4B-A213-33714E629B6BQ58482081-DDE6FB38-7D0A-4CCC-9ACD-8D8BAF3D10B0
P2860
Drug-induced lupus: an update on its dermatologic aspects.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Drug-induced lupus: an update on its dermatologic aspects.
@ast
Drug-induced lupus: an update on its dermatologic aspects.
@en
Drug-induced lupus: an update on its dermatologic aspects.
@nl
type
label
Drug-induced lupus: an update on its dermatologic aspects.
@ast
Drug-induced lupus: an update on its dermatologic aspects.
@en
Drug-induced lupus: an update on its dermatologic aspects.
@nl
prefLabel
Drug-induced lupus: an update on its dermatologic aspects.
@ast
Drug-induced lupus: an update on its dermatologic aspects.
@en
Drug-induced lupus: an update on its dermatologic aspects.
@nl
P2093
P2860
P356
P1433
P1476
Drug-induced lupus: an update on its dermatologic aspects.
@en
P2093
P2860
P304
P356
10.1177/0961203309106176
P577
2009-10-01T00:00:00Z